CAC Software vs ASSURE Wearable ECG
AI Verdict
Choose CAC Software if…
Choose Imbio's CAC Software if you need to perform automated, quantitative risk assessment for coronary artery disease using existing non-contrast chest CT scans. This tool is ideal for radiologists and cardiologists seeking to quickly obtain Agatston scores, arterial age, and 3D visualizations to aid in patient stratification and treatment planning based on calcification levels.
View CAC Software →Choose ASSURE Wearable ECG if…
Choose Kestra Medical Technologies' ASSURE Wearable ECG if you require continuous, real-time heart rate monitoring and data collection for at-risk cardiac patients. This wearable device is best suited for ongoing patient management, providing automatic episode storage, alert-based notifications, and physiologic trend data for timely clinician review and intervention.
View ASSURE Wearable ECG →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | CAC Software | ASSURE Wearable ECG |
|---|---|---|
| Deployment | Cloud-based (SaaS), integrates with PACS | The ASSURE system is intended for use by a patient during their normal daily activities primarily in the home or community setting, but also hospitals, medical clinics, healthcare facilities and transport. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
ASSURE Wearable ECGWhile Tool A offers excellent integration into existing clinical workflows for radiologists and cardiologists, Tool B demonstrates a more comprehensive focus on usability for both patients and clinicians. Its 'Empathy Powered Design' prioritizes patient comfort and ease of wear for continuous monitoring, complemented by a clear patient app and clinician platform. The in-person training and high reported patient compliance further highlight its superior usability in a real-world context.
Clinical Value
ASSURE Wearable ECGWhile Tool A provides valuable risk stratification data for coronary artery disease from CT scans, Tool B offers continuous, real-time monitoring and detection of life-threatening arrhythmias, which can lead to immediate, life-saving interventions. Its proven effectiveness in clinical studies, high patient compliance, and ability to detect previously undiagnosed arrhythmias demonstrate a direct and immediate impact on patient outcomes.
Pricing & Value
TieBoth Imbio's CAC Software and Kestra's ASSURE Wearable ECG require direct contact for pricing information, making a direct comparison of their cost and value proposition impossible with the available data. Neither tool provides public details on pricing models, subscription tiers, or demonstrated return on investment.
Enterprise Readiness
CAC SoftwareWhile both are FDA-cleared, HIPAA compliant, and offer BAAs, Tool A provides more explicit and flexible deployment options including robust on-premise solutions and integration with numerous established AI platforms and PACS systems. This breadth of integration and deployment flexibility makes it highly adaptable to diverse enterprise IT infrastructures and existing clinical workflows.
Innovation
ASSURE Wearable ECGTool B demonstrates a broader and more active innovation pipeline, combining novel hardware design (SensorFit Garment) with advanced AI algorithms (Adaptive Patient Intelligence) for superior data quality and patient comfort in continuous monitoring. Its ongoing collaborations to integrate additional diagnostic capabilities, like cuffless blood pressure monitoring, further highlight its commitment to expanding its innovative offerings.
Support & Docs
ASSURE Wearable ECGTool B offers more comprehensive and readily accessible support, including a 24/7 helpline for both patients and providers, along with dedicated patient handbooks and in-person training. While Tool A provides documentation upon request and general support, Tool B's multi-faceted approach to support, especially for patients using a wearable device, is more robust.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | CAC Software | ASSURE Wearable ECG |
|---|---|---|
| Name | CAC Software | ASSURE Wearable ECG |
| Company | Imbio | Kestra Medical Technologies |
| Description | Automated image post-processing algorithms designed to help radiologists and cardiologists determine the location and calculate the amount of calcification within the coronary arteries in patients who have undergone a non-contrast, chest computed tomography (CT). | A non-therapeutic device for continuous heart rate monitoring and data collection, integrated into their digital healthcare platform for at-risk cardiac patients. |
| Categories | Cardiology AI | Cardiology AI, Wearables & Remote Monitoring (RPM) |
| Specialties | Cardiology, Radiology | Cardiology |
| Key Features | Automated image post-processing for coronary artery calcification, Quantification of calcification within coronary arteries, Outputs Agatston score, arterial age, calcified lesion mass and volume, Provides 3D visualizations and annotated images, Non-invasive analysis from non-contrast chest CT scans, Integrates into existing DICOM viewing workflow, Supports risk assessment for coronary artery disease, Deep-learning based analysis | Wearable ECG device for continuous heart rate monitoring, SensorFit Garment with non-adhesive, embedded, and cushioned ECG sensors, ASSURE Detection Algorithm with Quad Channel Processingu2122, Adaptive Patient Intelligenceu2122 for filtering motion artifacts, Automatic episode storage, Alert-based notifications, Physiologic trend data, Kestra CareStation remote patient data platform for clinician review |
Videos
Demos, reviews, and walkthroughs featuring CAC Software and ASSURE Wearable ECG.